Sort
30,917 grants matching “tumor microenvironment”
Novel roles of STAT2 and IFN-I in tumorigenesis and responses to therapy
$483,558George Robert Stark · Cleveland Clinic Lerner Com-Cwru · P01 · FY2025 · CA
Novel roles of STAT2 and IFN-I in tumorigenesis and responses to therapy
$483,558George Robert Stark · Cleveland Clinic Lerner Com-Cwru · P01 · FY2022 · CA
Neoadjuvant checkpoint blockade for recurrent glioblastoma
$483,557Robert M Prins · University Of California Los Angeles · R01 · FY2023 · CA
TLR Agonist Nano-Immune Therapy for Peritoneal Metastases
$483,556Rita Elena Serda · University Of New Mexico Health Scis Ctr · R01 · FY2024 · CA
Defining and characterizing microenvironmental drivers of disseminated tumor cell dormancy in brain
$483,488Cyrus M Ghajar · Fred Hutchinson Cancer Research Center · R01 · FY2020 · CA
RADIATION-ENHANCED NANOBIOPOLYMER THERAPEUTICS THROUGH THE BLOOD-BRAIN BARRIER
$483,486Gary D Kao · University Of Pennsylvania · RC1 · FY2009 · CA
Cellular and molecular analysis of B lymphocyte development and selection
$483,457Joao Pereira · Yale University · R01 · FY2021 · AI
Project 1: Overcoming therapeutic resistance in pancreatic cancer through epigenetic reprogramming
$483,451Ronald M. Evans · Salk Institute For Biological Studies · P01 · FY2024 · CA
Computational Methods for Identifying Non-coding Cancer Drivers
$483,437Ekta Khurana · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · CA
Estrogen Suppression as a Strategy to Enhance Immunotherapy Efficacy in EGFR-Mutated Non-Small Cell Lung Cancer
$483,395Joseph Nicholas Bodor · Research Inst Of Fox Chase Can Ctr · R21 · FY2024 · CA
A novel engineered IL-21-based immunocytokine as a therapeutic approach for tumor targeting in renal cancer
$483,395Petr B. Makhov · Research Inst Of Fox Chase Can Ctr · R21 · FY2024 · CA
Targeting Systems Vulnerabilities in the EGFR/HER3/HER2 Oncogenic Signaling Circuitry: New Precision Therapies for Oral Cancer
$483,360J. Silvio Gutkind · University Of California, San Diego · R01 · FY2025 · DE
Targeting PPT1 in the Tumor Microenvironment
$483,340Ravi K Amaravadi · Wistar Institute · P01 · FY2021 · CA
Effect of tumor cell glutamine metabolism on anti-tumor immunity in TNBC
$483,313Jin Chen · Vanderbilt University Medical Center · R01 · FY2022 · CA
Effect of tumor cell glutamine metabolism on anti-tumor immunity in TNBC
$483,313Jin Chen · Vanderbilt University Medical Center · R01 · FY2023 · CA
MDSCs in Ovarian Cancer
$483,308Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2019 · CA
Improving treatment of HER2+ breast cancer brain metastasis by targeting lipid metabolism
$483,164Rakesh K. Jain · Massachusetts General Hospital · R01 · FY2021 · CA
Targeting Chemotherapy-induced Breast Cancer Stemness
$483,120Shizhen Emily Wang · University Of California, San Diego · R01 · FY2017 · CA
Causes and Consequences of Acid pH in Tumors
$483,104Robert J Gillies · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2010 · CA
Engineering bZIP family transcription factors for therapeutic T-cell persistence and effector function
$483,041Glenna Wink Foight · Baylor College Of Medicine · R37 · FY2024 · CA
Mechanisms of Epigenetic Plasticity in PDAC
$483,032Chunling Yi · Georgetown University · R01 · FY2023 · CA
Mechanisms of Epigenetic Plasticity in PDAC
$483,032Chunling Yi · Georgetown University · R01 · FY2022 · CA
Matrix density promotes pro-tumorigenic hormone actions in breast cancer
$483,032Linda A. Schuler · University Of Wisconsin-Madison · R01 · FY2021 · CA
Comparative modeling of sarcoma microenvironments for the discovery of biomarkers and tumor vulnerabilities
$482,921Jlenia Guarnerio · Cedars-Sinai Medical Center · R01 · FY2022 · CA
Project 2 Human Tumor Analysis
$482,856Sylvia Katina Plevritis · Stanford University · U54 · FY2024 · CA